Company lists
The Haryana edition · 2026

Biopharma outsourcingcompanies in Haryana

CDMO, API & small molecules, CRO & clinical, regulatory & consulting, listed and more: the companies building biopharma outsourcing in Haryana, with their founders, funding, team size and business models.

105 company profiles38 with reported revenue2 with recorded fundingOctober 2026 edition
Haryana · Photo: Wikimedia Commons (Creative Commons Attribution-ShareAlike 4.0)

Recent biopharma outsourcing business events in India

Funding, M&A, contract wins and launches involving 2,490 biopharma outsourcing companies in India, last 24 months: 81 M&A deals · 18 Contracts · 18 funding rounds · 3 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

M&AAcquisition · Announced

Skymap pharmaceuticals acquires Indian Medicines Pharmaceutical Corporation Ltd

The Indian government has officially approved the acquisition of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) by Skymap Pharmaceuticals Pvt Ltd for ₹121 crore.

Pharmaceuticals
M&AAcquisition · Announced

True north acquires Embio

According to reports, True North invested about INR 478 crores to acquire a 25 percent stake in Embio.

Pharmaceuticals
M&AAcquisition · Completed

Sunways acquires Indoco remedies

Indoco Remedies has successfully completed the transfer of its ophthalmic business division to Sunways (India) Private Limited. This strategic move, finalised on May 18, 2026, involves…

Pharmaceuticals
M&AAcquisition · Announced

Gujarat themis biosyn acquires Sanofi

Introduction Shares of Gujarat Themis Biosyn Ltd surged sharply after the company announced a major acquisition deal with Sanofi.

Pharmaceuticals
LaunchSynchronous Motors Market Size 2026 Report

Datam intelligence

DataM Intelligence has unveiled its latest report on the 'Synchronous Motors Market Size 2026' delivering powerful insights into key trends, future growth opportunities, and evolving…

Report
ContractSupply

Panacea biotec · client: Central Medical Services Society (CMSS)

Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…

Healthcare
M&AAcquisition · Completed

Jubilant ingrevia acquires Remidex Pharma

Jubilant Ingrevia has successfully acquired a 100% equity stake in Remidex Pharma Private Limited.

Pharmaceutical
M&AMerger · Announced

EPL acquires Indovida India Private Limited

EPL Limited and Indovida India Private Limited have today signed definitive agreements for a merger. The combined platform will have a valuation of ~$2 billion.

Rigid PET packaging
ContractTechnology

Shilpa Biologicals · client: Steincares

SteinCares, a specialty healthcare company in Latin America, entered into a strategic licensing agreement with Shilpa Biologicals Pvt. Ltd.

Healthcare
M&AAcquisition · Rumored

Consortium led by Warburg Pincus and Mubadala acquires Encube ethicals

Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals, ET…

Manufacturing
M&AAcquisition · Rumored

Warburg Pincus and Mubadala acquires Encube ethicals

Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals

Contract Manufacturing
M&AAcquisition

Dishman Pharmaceuticals and Chemicals acquires Carbogen-Amcis

Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) with its acquisition of Carbogen-Amcis from Solutia

M&AAcquisition · Completed

Eris lifesciences acquires SWISS PARENTERALS

New Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited, making it a wholly owned subsidiary

FundingZero-coupon bonds

Jubilant bhartia group

Two Jubilant Bhartia Group subsidiaries raised a combined 56.50 billion rupees through zero-coupon bonds in June to fund the acquisition of a 40% stake in Hindustan Coca-Cola Holdings.

M&AAcquisition · Announced

Aurobindo pharma acquires Khandelwal laboratories

Aurobindo Pharma, a wholly owned subsidiary of Aurobindo Pharma, at its meeting held on Monday, i.e., January 1, 2026, has approved the acquisition of the non-oncology prescription…

Pharmaceuticals
M&AAcquisition · Completed

Cactus acquires Baker Hughes Company’s Surface Pressure Control business

Cactus, Inc. today announced the completion of the acquisition of a majority interest in Baker Hughes Company’s Surface Pressure Control business.

Oil & Gas Services
M&AAcquisition · Announced

Piramal Pharma acquires Hemmo pharmaceuticals

Piramal Pharma Limited (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd., an Indian manufacturer of synthetic peptide APIs (active…

M&AAcquisition · Completed

Auro pharma acquires Khandelwal laboratories

Aurobindo Pharma Ltd said its wholly owned arm, Auro Pharma Ltd, has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Ltd on a…

Pharmaceuticals
ContractSupply

Panacea biotec · client: Unicef

Earlier in October, UNICEF also placed a significant order for polio vaccines. Panacea Biotec received the letter of award (LoA) as part of a long-term agreement to supply bOPV in 10 and…

Healthcare
M&AAcquisition · Announced

Nowonomics acquires Centaur

On Wednesday, Dec. 10, it was announced that Swedish fund management company Centaur is selling its Sweden Quality fund to Nowonomics.

Fund management
M&AAcquisition · Announced

Eris lifesciences acquires SWISS PARENTERALS

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of…

M&AMerger · Announced

Sequent scientific acquires Viyash Lifesciences

The National Company Law Tribunal (NCLT) has approved the merger of SeQuent Scientific, a leading player in the global animal health industry, and Viyash Lifesciences, an integrated…

M&AAcquisition · Completed

Quadria capital acquires Encube ethicals

Quadria Capital bought around 15% in Encube for $100-120 million in June 2021, valuing it close to $1 billion.

Contract drug maker
M&AAcquisition · Announced

Ang lifesciences india acquires Mansa Print & Publishers

ANG Lifesciences India, a fast-growing organisation with an ultra-modern fully integrated, manufacturing facility dedicated to dry powder injectables (SVP), has acquired the printing and…

Printing & Packaging
M&AAcquisition · Rumored

Na acquires Encube ethicals

Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd.

Contract drug maker / CDMO
M&AAcquisition · Announced

Intocell acquires Piramal pharma solutions

Piramal Pharma Solutions signed a memorandum of understanding with IntoCell to develop ADCs.

M&AAcquisition · Announced

Piramal pharma solutions acquires Intocell

Piramal Pharma Solutions signed a memorandum of understanding with IntoCell to develop ADCs.

Biotechnology / ADC development
M&AAcquisition · Announced

Jusmiral Holdings Limited acquires Cohance lifesciences

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor for an on-market sale of 8.93% shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited)…

M&AMerger · Completed

Cohance acquires Suven

SAM also advised on the subsequent merger of Cohance with and into Suven, upon which Suven was renamed as Cohance.

Biopharma outsourcing companies in Haryana, by revenue

Browse biopharma outsourcing companies in Haryana by reported revenue, one-year revenue growth, revenue model, age and stage. The 38 companies below are the largest by their most recent reported revenue among 38 biopharma outsourcing companies in Haryana that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.

Showing 25 of 38

CDMO focused on manufacturing pharmaceutical formulations and quality assurance services

Biopharma outsourcing
₹1,255.72 crFY 2024-25
+15%2024–2025
783-92% 12 mo to Jun 2024LinkedIn · Oct 2026
20 yr2006
0none in 3 months

Provider of regulatory affair, quality control, and market strategy services to biopharma sector

Biopharma outsourcing
₹777.90 crFY 2024-25
+21%2024–2025
899+16% 12 mo to Jul 2024LinkedIn · Oct 2026
25 yr2001
0none in 3 months

Developer of biosimilars, vaccines and natural products

Diversified pharmaceuticals
₹584.97 crFY 2023-24
+14%2023–2024
3,086+10% 12 mo to Jul 2024LinkedIn · Oct 2026
42 yr1984
1postings · last posted Sep 2026

Developer of therapeutics for oncology and dermatology

Oncology
₹368.79 crFY 2024-25
+24%2024–2025
266+31% 12 mo to Jul 2024LinkedIn · Oct 2026
21 yr2005
0none in 3 months

Pharmaceutical contract development and manufacturing organization focused on pharmaceutical industry

Biopharma outsourcing
₹280.01 crFY 2024-25
+29%2024–2025
236+21% 12 mo to Aug 2024recorded Aug 2024
7 yr2019
0none in 3 months

Specialty chemical manufacturing company, operating in the pharmaceutical industry, with a focus on producing chemicals for various applications, including pharmaceuticals and agriculture

Biopharma outsourcing
₹162.69 crFY 2021-22
Not reported
26+3% 12 mo to Mar 2024LinkedIn · Oct 2026
29 yr1997
0none in 3 months

Contract manufacturer of formulations

Biopharma outsourcing
₹178.12 crFY 2024-25
+3%2024–2025
139+17% 12 mo to Sep 2024LinkedIn · Oct 2026
39 yr1987
0none in 3 months · last posted Feb 2026

Pharmaceutical company offers distribution, marketing, outsourcing, and manufacturing of pharmaceutical products

Biopharma outsourcing
₹126.91 crFY 2024-25
-5%2024–2025
173+629% 12 mo to Mar 2024LinkedIn · Jul 2026
35 yr1991
0none in 3 months · last posted Jun 2026

Contract manufacturer of nutraceutical and health supplements, logistics and regulatory services provider

Biopharma outsourcing
₹120.47 crFY 2024-25
+215%2024–2025
60LinkedIn · Jul 2026
11 yr2015
0none in 3 months · last posted Jun 2026

Developer and manufacturer of impurities and phytochemicals

Biopharma outsourcing
₹66.60 crFY 2024-25
+14%2024–2025
304+37% 12 mo to Sep 2024LinkedIn · Jul 2026
25 yr2001
0none in 3 months · last posted Jun 2026

CDMO focused on manufacturing soft gel pharmaceutical products

Biopharma outsourcing
₹56.76 crFY 2024-25
+51%2024–2025
19+31% 12 mo to Mar 2024LinkedIn · Jul 2026
12 yr2014
0none in 3 months

CDMO specializing in protein production and purification

Biopharma outsourcing
₹45.93 crFY 2024-25
+65%2024–2025
97-11% 12 mo to Sep 2024recorded Sep 2024
21 yr2005
0none in 3 months

CDMO focused on manufacturing of syrup and marketing services

Traditional pharmaceuticals
₹35.04 crFY 2024-25
+23%2024–2025
33LinkedIn · Jul 2026
30 yr1996
0none in 3 months

CDMO focused on manufacturing dietary supplements

Biopharma outsourcing
₹30.06 crFY 2021-22
Not reported
24+4% 12 mo to Feb 2024recorded Feb 2024
9 yr2017
—No postings tracked

WHO GMP certified manufacturer and supplier of ophthalmology products

Biopharma outsourcing
₹31.70 crFY 2022-23
Not reported
170+0% 12 mo to Sep 2024recorded Sep 2024
55 yr1971
—No postings tracked

Pharmaceutical company offering a diverse range of products including injectables, tablets, syrups, and personal care items and marketing services

Biopharma outsourcing
₹27.66 crFY 2024-25
-4%2024–2025
—Not available
17 yr2009
0none in 3 months

Leading health and protein supplement manufacturer

Biopharma outsourcing
₹24.69 crFY 2024-25
-10%2024–2025
22LinkedIn · Jul 2026
7 yr2019
0none in 3 months

Provider of marketing services to biopharma sector

Biopharma outsourcing
₹18.79 crFY 2024-25
+47%2024–2025
—Not available
14 yr2012
0none in 3 months

CDMO focused on manufacturing drugs formulations for biopharma sector

Biopharma outsourcing
₹15.46 crFY 2024-25
+7%2024–2025
—Not available
14 yr2012
0none in 3 months

Provider of packaging services for pharmaceutical sector

Biopharma outsourcing
₹13.77 crFY 2024-25
+25%2024–2025
—Not available
15 yr2011
0none in 3 months

Contract manufacturer of WHO-GMP certified pharmaceutical formulations

Traditional pharmaceuticals
₹13.54 crFY 2024-25
+1%2024–2025
116LinkedIn · Jul 2026
12 yr2014
0none in 3 months

Pharmaceutical company that manufactures and markets a range of pharmaceutical products

Biopharma outsourcing
₹12.87 crFY 2024-25
+15%2024–2025
25LinkedIn · Jul 2026
8 yr2018
0none in 3 months

Provider of medical technology solutions for radiology and pain management. It distributes and services handheld medical X-ray systems and laser pain management devices. The company also offers medical simulators for educational purposes. Its product portfolio caters to both human and veterinary healthcare sectors. The organization supports its products with sales, marketing, and service capabilities.

Services for healthcare providers
₹11.94 crFY 2024-25
Not reported
28LinkedIn · Jul 2026
45 yr1981
1postings · last posted Aug 2026

Contract manufacturer and exporter of herbal and allopathic medicines, nutraceuticals, and cosmetic products

Biopharma outsourcing
₹11.57 crFY 2024-25
+8%2024–2025
—Not available
16 yr2010
0none in 3 months

Life sciences consulting firm specializing in regulatory affairs, pharmacovigilance, and quality services, accelerating product registrations and ensuring compliance through smart RegTech and deep industry expertise

Biopharma outsourcing
₹11.27 crFY 2023-24
+43%2023–2024
96LinkedIn · Jul 2026
17 yr2009
0none in 3 months
38 of 105 companies shown here · the full list is on Radar
Fliar Radar

Explore all 105 biopharma outsourcing companies in Haryana on Radar

This page shows the top 38. Radar has the complete, filterable list with contacts and live company signals.

Open biopharma outsourcing in Haryana on Radar
  • Every company, not just 50All 105 biopharma outsourcing companies in Haryana, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore biopharma outsourcing companies in Haryana by what you are looking for

Browse biopharma outsourcing companies in Haryana, including CDMOs, contract manufacturers and clinical research organisations. See pharma outsourcing startups in Haryana, listed companies and who is hiring.

7 ways to explore biopharma outsourcing in Haryana

CDMO & contract manufacturing companiesAPI production & small molecule companiesCRO & clinical research companiesPharma consulting & regulatory affairs companiesListed biopharma outsourcing companies in HaryanaBiopharma outsourcing startups in Haryana

CDMO & contract manufacturing companies

Contract development and manufacturing organisations producing formulations for pharma brands.

  1. Windlas

    Provider of regulatory affair, quality control, and market strategy services to biopharma sector

    Biopharma outsourcing
    See in list
  2. Panacea Biotec

    Developer of biosimilars, vaccines and natural products

    Diversified pharmaceuticals
    See in list
  3. Softcaps

    CDMO focused on manufacturing soft gel pharmaceutical products

    Biopharma outsourcing
    See in list
  4. Jawa Pharmaceuticals

    WHO GMP certified manufacturer and supplier of ophthalmology products

    Biopharma outsourcing
    See in list
  5. Nutriwell Laboratories

    Leading health and protein supplement manufacturer

    Biopharma outsourcing
    See in list

API production & small molecule companies

Manufacturers of active pharmaceutical ingredients, small molecules and peptides.

  1. Innova Captab

    CDMO focused on manufacturing pharmaceutical formulations and quality assurance services

    Biopharma outsourcing
    See in list
  2. Windlas

    Provider of regulatory affair, quality control, and market strategy services to biopharma sector

    Biopharma outsourcing
    See in list
  3. Beta Drugs

    Developer of therapeutics for oncology and dermatology

    Oncology
    See in list
  4. Nichepharm

    Pharmaceutical contract development and manufacturing organization focused on pharmaceutical industry

    Biopharma outsourcing
    See in list
  5. SB Organics

    Specialty chemical manufacturing company, operating in the pharmaceutical industry, with a focus on producing chemicals for various applications, including pharmaceuticals and agriculture

    Biopharma outsourcing
    See in list

CRO & clinical research companies

Contract research organisations running clinical development, trials and bioanalytical studies.

  1. MediCeption

    Provider of medical writing, clinical trial support, market research and HEOR and training services

    Biopharma outsourcing
    See in list
  2. Catabatic

    Provider of IT service suite solutions

    It services
    See in list
  3. Apothecaries

    Clinical research organization with expertise in clinical trial, site management, regulatory affairs and bioavailability studies

    Biopharma outsourcing
    See in list
  4. Growdea Technologies

    Provides IT services suite

    Biopharma outsourcing
    See in list
  5. Skymap

    Provider of contract based drug development services

    Biopharma outsourcing
    Website

Pharma consulting & regulatory affairs companies

Consultants supporting regulatory affairs, market access and strategy for pharma firms.

  1. Ddregpharma

    Life sciences consulting firm specializing in regulatory affairs, pharmacovigilance, and quality services, accelerating product registrations and ensuring compliance through smart RegTech and deep industry expertise

    Biopharma outsourcing
    See in list
  2. Saliegral Global

    Consulting services for regulatory and digital marketing support

    Biopharma outsourcing
    See in list
  3. XceliSys

    Provider of strategic consulting services for the biopharmaceutical and investment sectors

    Management consulting services
    Website
  4. api first - pharma regulatory consultants

    API FIRST is a pharma regulatory consulting service which deals with Drug regulatory filing and subsequent approval processes of drugs.

    Biopharma outsourcing
    Website
  5. NeuroLeadership

    Provider of business skill training and consulting services for biopharma sector

    Biopharma outsourcing
    Website

Listed biopharma outsourcing companies in Haryana

Publicly listed biopharma outsourcing companies in Haryana.

  1. Innova Captab

    CDMO focused on manufacturing pharmaceutical formulations and quality assurance services

    Biopharma outsourcing
    See in list
  2. Windlas

    Provider of regulatory affair, quality control, and market strategy services to biopharma sector

    Biopharma outsourcing
    See in list
  3. Panacea Biotec

    Developer of biosimilars, vaccines and natural products

    Diversified pharmaceuticals
    See in list
  4. Beta Drugs

    Developer of therapeutics for oncology and dermatology

    Oncology
    See in list
4 companies in Haryana

Biopharma outsourcing startups in Haryana

Recently founded biopharma outsourcing companies in Haryana.

  1. Efpia

    CDMO focused on manufacturing pharmaceutical drugs

    Biopharma outsourcing
    Website
  2. APM Medichem

    Provider of sourcing, manufacturing, compliance, and delivery solutions for pharma, nutra, and ayurveda brands

    Biopharma outsourcing
    Website
  3. XceliSys

    Provider of strategic consulting services for the biopharmaceutical and investment sectors

    Management consulting services
    Website
  4. Criticine Care

    Leading pharma company specializing in critical care products

    Biopharma outsourcing
    Website
  5. Ayurcrafts

    Manufacturer of ayurvedic and nutraceutical medicines in multiple product formats

    Biopharma outsourcing
    Website
14 companies in Haryana

Biopharma outsourcing companies hiring in Haryana

Biopharma outsourcing companies in Haryana with open roles right now.

  1. Panacea Biotec

    Developer of biosimilars, vaccines and natural products

    Diversified pharmaceuticals
    See in list
  2. Stanford Laboratories

    Contract manufacturer of formulations

    Biopharma outsourcing
    See in list
  3. EVOLET

    Pharmaceutical company offers distribution, marketing, outsourcing, and manufacturing of pharmaceutical products

    Biopharma outsourcing
    See in list
  4. Fermentis Life Sciences

    Contract manufacturer of nutraceutical and health supplements, logistics and regulatory services provider

    Biopharma outsourcing
    See in list
  5. Pharmaffiliates Analytics & Synthetics

    Developer and manufacturer of impurities and phytochemicals

    Biopharma outsourcing
    See in list
8 companies in Haryana
The business behind the activity

Biopharma outsourcing financials in Haryana

Revenue, profit and growth from the filed annual accounts of 38 biopharma outsourcing companies in Haryana for FY24-25 — 42 of the 105 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 74% of the revenue, so medians describe the typical company better than totals.

combined revenue, FY24-25₹3,293.88 cr

38 companies filing accounts

combined net profit₹321.35 cr

9.8% aggregate margin

are profitable84%

32 of 38 companies

median revenue~₹14.6 cr

the typical company

median revenue growth+16%

into FY24-25

earned by the top five74%

revenue concentration

Six-year view

Combined revenue of filing companies

₹1,388.73 crFY19-2035 filers
₹1,606.26 crFY20-2137 filers
₹2,194.14 crFY21-2237 filers
₹2,492.65 crFY22-2338 filers
₹10,203.77 crFY23-2438 filers
₹3,293.88 crFY24-2538 filers

The number of companies filing changes each year; the three-year cohort below compares like with like.

Like-for-like

The same 36 companies over three years

+32%
FY22-23₹2,483.90 cr₹143.38 cr net
FY23-24₹10,192.43 cr₹7,568.21 cr net
FY24-25₹3,290.54 cr₹321.33 cr net

Companies with accounts for all three years, so growth is not an artefact of who filed.

Scale and profit

Bigger companies are far more often profitable

Under ₹1 cr683% profitable
₹1–10 cr875% profitable
₹10–100 cr1788% profitable
₹100–1,000 cr786% profitable
Over ₹1,000 cr0—

Companies by FY24-25 revenue. Bars show how many companies sit in each band.

Momentum

How fast revenue moved into FY24-25

Shrinking10
0–20%9
20–50%13
50–100%2
Doubled+3

37 companies with accounts for both years; median growth +16%.

Profitability

Profit is concentrated at the top

32profitable
6loss-making
9.8%aggregate margin
2.3%median margin

The aggregate margin is pulled up by a few large filers; the median shows the typical company.

Growth leaders · ₹10 cr+ revenue

Fastest growing, FY24-25

CompanyGrowthRevenue
Fermentis Life SciencesFERMENTIS LIFE SCIENCES PRIVATE LIMITED+215%₹120.47 cr
Premas BiotechPREMAS BIOTECH PRIVATE LIMITED+65%₹45.93 cr
SoftcapsTITANIUM TECHNOLOGIES (INDIA) PRIVATE LIMITED+51%₹56.76 cr
Sunwin healthcare Web designSUNWIN HEALTHCARE PRIVATE LIMITED+47%₹18.79 cr
Atulya MedilinkATULYA MEDILINK PRIVATE LIMITED+34%₹12.59 cr
NichepharmNICHEPHARM LIFESCIENCES PRIVATE LIMITED+29%₹280.01 cr
Profit leaders · ₹10 cr+ revenue

Highest net margins, FY24-25

CompanyMarginRevenue
S.K. Jain TradingS K JAIN TRADING PRIVATE LIMITED
NichepharmNICHEPHARM LIFESCIENCES PRIVATE LIMITED24.2%₹280.01 cr
Pharmaffiliates Analytics & SyntheticsPHARMAFFILIATES PRIVATE LIMITED17.4%₹66.60 cr
Innova CaptabINNOVA CAPTAB LIMITED9.2%₹974.84 cr
WindlasWINDLAS BIOTECH LIMITED7.8%₹777.52 cr
Beta DrugsBETA DRUGS LIMITED6.8%₹226.39 cr
Inside the industry

Sub-sectors compared, FY24-25

Sub-sectorCompaniesRevenueMedian revenueProfitableMargin
Biopharma outsourcing33₹3,015.16 cr~₹15.5 cr88%10.3%
Leaders

Largest biopharma outsourcing companies by revenue, FY24-25

Company · legal entityRevenueNet resultMarginGrowth
Innova CaptabINNOVA CAPTAB LIMITED₹974.84 cr₹89.47 cr9.2%+11%
WindlasWINDLAS BIOTECH LIMITED₹777.52 cr₹60.65 cr7.8%+21%
NichepharmNICHEPHARM LIFESCIENCES PRIVATE LIMITED₹280.01 cr₹67.73 cr24.2%+29%
Beta DrugsBETA DRUGS LIMITED₹226.39 cr₹15.43 cr6.8%+14%
Stanford LaboratoriesSTANFORD LABORATORIES PRIVATE LTD₹178.12 cr−₹4.00 cr-2.2%+3%
EVOLETEvolet Healthcare Private Limited₹123.25 cr₹7.41 cr6.0%-3%
Fermentis Life SciencesFERMENTIS LIFE SCIENCES PRIVATE LIMITED₹120.47 cr₹2.28 cr1.9%+215%
SB OrganicsS B ORGANICS LTD₹85.97 cr−₹4.18 cr-4.9%-50%
S.K. Jain TradingS K JAIN TRADING PRIVATE LIMITED-99%
Pharmaffiliates Analytics & SyntheticsPHARMAFFILIATES PRIVATE LIMITED₹66.60 cr₹11.61 cr17.4%+14%
Some figures are available to Radar members.Log in to Radar to see every figure

Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.

For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding and MCA filings data. Use it through the Investor Intelligence API and MCA financials feeds, or explore every company, filing and investor in Radar.

Capital & corporate activity

Biopharma outsourcing funding and M&A across India

193 recorded equity rounds have gone to 2,490 biopharma outsourcing companies in India — how much, at which stage, into which sub-sectors, from whom, and how Haryana compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months2

US$270.00m

equity rounds, last 24 months7

US$425.09m

raised over five yearsUS$1.28bn

51 rounds in India

M&A deals, India81

last 24 months

Capital by year

Equity funding into biopharma outsourcing in India

amount rounds
$84m201811
$134m20199
$62m202011
$435m202116
$315m202214
$90m20238
$19m20246
$155m20256
$270m20261

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$435.16m across 16 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$119.62m12 rounds · median US$500k
SeedUS$14.38m11 rounds · median US$1.29m
Series AUS$80.53m9 rounds · median US$4.40m
Series BUS$106.78m7 rounds · median US$16.27m
Series CUS$255.00m3 rounds · median US$80.00m
Series D+US$284.18m2 rounds · median US$142.09m
Private equityUS$423.40m7 rounds · median US$68.00m
Where the money went · five years

Most-funded sub-sectors

Biopharma outsourcingUS$982.10m45 rounds · 35 companies
Traditional pharmaceuticalsUS$271.81m2 rounds · 2 companies
Contract manufacturersUS$29.48m2 rounds · 2 companies
Medical research labsUS$500k1 rounds · 1 companies
Food safety testingUS$0k1 rounds · 1 companies
Corporate activity · last 24 months

M&A in India

67Acquisition
14Merger

Most active acquirers

  1. Jubilant bhartia group6
  2. Sequent scientific5
  3. Optimus4
  4. Eris lifesciences3
  5. Cactus3

Most acquired or merged

  1. Schott poonawalla7
  2. Encube ethicals4
  3. OTRS AG4
  4. SWISS PARENTERALS3
  5. Gland pharma3

Each deal appears in the events strip at the top of the page.

Founders and momentum in Haryana

Meet the people behind biopharma outsourcing companies in Haryana. 32 of 105 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Keep exploring biopharma outsourcing in India and nearby markets.

Coming soon